Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Open questions in bioequivalence

A Marzo1

  • 1IPAS S.A., Stabio, Switzerland.

Pharmacological Research
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Bioequivalence studies are crucial for generic drug approval. This paper addresses challenges in conducting these studies, offering solutions for complex cases like variable active ingredients and ethical considerations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

openBF: an open-source finite volume 1D blood flow solver.

Physiological measurement·2024
Same author

On the application of sound radiation force for focusing of powder stream in directed energy deposition.

Ultrasonics·2022
Same author

Delivering computationally-intensive digital patient applications to the clinic: An exemplar solution to predict femoral bone strength from CT data.

Computer methods and programs in biomedicine·2021
Same author

Improved biomechanical metrics of cerebral vasospasm identified via sensitivity analysis of a 1D cerebral circulation model.

Journal of biomechanics·2019
Same author

Hydraulic reliability of a horizontal wetland for wastewater treatment in Sicily.

The Science of the total environment·2018
Same author

The Role of Hemodynamics in Intracranial Bifurcation Arteries after Aneurysm Treatment with Flow-Diverter Stents.

AJNR. American journal of neuroradiology·2017
Same journal

GLP-1 Receptor Agonist Therapy in Children and Adolescents with Obesity: A Network Meta-Analysis of Differential Cardiometabolic Efficacy and Safety Profiles.

Pharmacological research·2026
Same journal

Sinomenine regulates the AKT/FOXO3/GLUL pathway to inhibit pulmonary fibroblast-to-myofibroblast transition via α7nAChR against rheumatoid arthritis associated interstitial lung disease.

Pharmacological research·2026
Same journal

Ketohexokinase: A central mediator of fructose-associated pathogenesis and promising therapeutic target.

Pharmacological research·2026
Same journal

GLP-1-based combination strategies for weight loss: Multi-target agents and combination therapies.

Pharmacological research·2026
Same journal

Cajaninstilbene acid in macrophage immunometabolism and angiogenesis: Mechanisms and therapeutic potential.

Pharmacological research·2026
Same journal

From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal Pain.

Pharmacological research·2026
See all related articles

Area of Science:

  • Pharmaceutical Sciences
  • Drug Development
  • Regulatory Affairs

Background:

  • Bioequivalence studies are essential for demonstrating the interchangeability of generic drugs.
  • Generic drug registration relies on abbreviated new drug applications (ANDA).
  • Current guidelines do not cover all challenges encountered in bioequivalence study design.

Purpose of the Study:

  • To identify and discuss significant challenges in planning and conducting bioequivalence studies.
  • To propose solutions for complex scenarios not addressed by existing guidelines.
  • To ensure the successful registration of generic pharmaceutical products.

Main Methods:

  • Case-by-case protocol development for complex bioequivalence studies.
  • Analysis of challenges including high variability, endogenous substances, long half-life, polymorphic metabolism, stereogenic centers, and ethical constraints.

Related Experiment Videos

  • Review of existing guidelines and literature to propose solutions.

    • Main Results:

    • Identified key challenges in bioequivalence study design and execution.
    • Provided potential solutions for managing high variability and endogenous substances.
    • Addressed strategies for drugs with long half-lives, polymorphic metabolism, stereogenic centers, and ethical limitations.

    Conclusions:

    • Addressing specific challenges on a case-by-case basis is vital for successful bioequivalence studies.
    • Proactive protocol design can overcome common and complex hurdles in generic drug development.
    • This work aids in the registration of generic drugs by providing practical solutions for difficult study designs.